Skip to content

Comparison of the Effects of Three Intravenous Anesthetics on Early Postoperative Recovery Quality in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Clinical Trial

Comparison of the Effects of Three Intravenous Anesthetics on Early Postoperative Recovery Quality in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102312
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients undergoing thoracoscopic lung surgery

Interventions

Group P:Anesthesia induction and maintenance were performed using propofol-based total intravenous anesthesia
Group R:Anesthesia induction and maintenance were performed using remimazolam-based total intravenous anesthesia (TIVA)
Group C:Anesthesia induction and maintenance were performed using ciprofol-based total intravenous anesthesia (TIVA)

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=65 years; 2. American Society of Anesthesiologists (ASA) Physical Status Classification: I-III; 3. Scheduled for elective thoracoscopic wedge resection, segmentectomy, or lobectomy; 4. Expected duration of surgery >=1.5 hours.

Exclusion criteria

Exclusion criteria: 1. Scheduled for elective thoracoscopic pneumonectomy; 2. Known contraindications to benzodiazepines, opioids, muscle relaxants, or investigational drugs; 3. History of psychiatric disorders, long-term use of psychotropic medications, or cognitive dysfunction; 4. History of alcohol abuse or substance misuse within the past two years; 5. Postoperative transfer to ICU with endotracheal intubation; 6. Currently enrolled in other clinical trials.

Design outcomes

Primary

MeasureTime frame
QoR-15 score on postoperative day 1 (POD 1);

Secondary

MeasureTime frame
Intraoperative hypotension;Emergence time;PACU delirium;PACU hypoxemia;Postoperative pain on POD 1, 2, and 3;Postoperative nausea and vomiting (PONV);QoR-15 scores on POD 2 and 3;Sleep quality assessed by Pittsburgh Sleep Quality Index (PSQI);Total perioperative analgesic consumption;Days at Home up to 30 Days after Surgery;30-day all-cause mortality;

Countries

China

Contacts

Public ContactYu Hai

West China Hospital, Sichuan University

yuhaishan117@yahoo.com+86 189 8060 1548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026